Steve Cagle is the CEO and a board member of Clearwater, assuming the CEO position in May 2018. Mr. Cagle is responsible for leading Clearwater’s strategic growth plan and for management of the company’s overall operations. He has extensive experience leading, innovating, and scaling healthcare and technology businesses, including having guided a number of companies through critical transformation periods.
Formerly, Mr. Cagle was president and CEO of Moberg Pharma North America, a subsidiary of Moberg Pharma AB (OMX:MOB), a publicly traded Swedish pharmaceutical company. Prior to its acquisition by Moberg AB, Mr. Cagle was president and CEO of Alterna LLC, a consumer healthcare products company.
Prior to joining Alterna, Mr. Cagle was a principal and executive team member of Sparta Systems, Inc., a software company that provides enterprise quality and compliance management software to pharmaceutical and medical device companies. During his nine-year tenure with the company, he served in numerous leadership positions including marketing, sales, operations, and product innovation and was responsible for sales and marketing programs, which contributed to Sparta’s leadership position in the pharmaceutical and medical device industries and to its 100-fold sales growth.
Mr. Cagle serves as the executive chairman of CMP Pharma where he has guided its transformation to an institutionally owned specialty pharmaceutical company.
Mr. Cagle holds a Master of Business Administration from New York University’s Leonard N. Stern School of Business and a Bachelor of Science degree in finance from Rutgers Business School in New Brunswick, N.J.